Novartis Investigative Site

Statesville, North Carolina 28625

0 studies enrolling now · 2 studies all time

What they study most

Atherosclerosis, Rheumatoid Arthritis

Studies at this site

• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• A Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) Patients — Completed